NivolumabGrade 3 diarrhoea: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1658卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32546-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：350 / 350

相关论文

共 50 条

[1] NivolumabGrade 3 diarrhoea: case report
[J]. Reactions Weekly, 2022, 1900 (1) : 256 - 256
[2] Ipilimumab/nivolumabGrade 3 colitis: case report
[J]. Reactions Weekly, 2023, 1986 (1) : 222 - 222
[3] Ipilimumab/nivolumabGrade 3 autoimmune hepatitis: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 359 - 359
[4] Ipilimumab/nivolumabGrade-3 enterocolitis : case report
[J]. Reactions Weekly, 2024, 2018 (1) : 253 - 253
[5] NivolumabGrade 5 colitis: case report
[J]. Reactions Weekly, 2020, 1822 (1) : 232 - 232
[6] NivolumabGrade II hepatotoxicity: case report
[J]. Reactions Weekly, 2020, 1789 (1) : 194 - 194
[7] NivolumabGrade 3 immune-related hepatitis: case report
[J]. Reactions Weekly, 2018, 1709 (1) : 185 - 185
[8] PanobinostatGrade 3 diarrhoea: case report
[J]. Reactions Weekly, 2023, 1980 (1) : 329 - 329
[9] NivolumabGrade 4 small intestinal perforation: case report
[J]. Reactions Weekly, 2021, 1846 (1) : 240 - 240
[10] AntineoplasticsGrade 3 neutropenia and diarrhoea: case report
[J]. Reactions Weekly, 2016, 1602 (1) : 30 - 30

← 1 2 3 4 5 →